STCube & Co., Inc.;Board of Regents, The University of Texas System
发明人:
申请号：
EP19196154.9
公开号：
EP3603651A1
申请日:
2016.05.20
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present application provides an in vitro method of identifying a target gene for cancer therapy comprising measuring an activity of an unmodified T cell and of a modified T cell； said unmodified T cell and said modified T cell each contacted with a suppressor cell； said modified T cell having a candidate gene knocked-down or knocked-out； wherein said candidate gene is identified as a target gene for cancer therapy if said activity is increased comparing said modified T cell to said unmodified T cell.
